Valuation: Avantor, Inc.

Market Cap 9.13B 7.88B 7.4B 6.74B 12.67B 873B 12.84B 86.69B 33.97B 437B 34.28B 33.54B 1,455B P/E 2026 *
40.4x
P/E 2027 * 28.9x
Enterprise Value 12.2B 10.54B 9.88B 9B 16.93B 1,167B 17.16B 116B 45.4B 585B 45.82B 44.82B 1,945B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.71x
Free-Float
95.49%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap.
31/7/26 Tax

Chief Financial Officer

-1,385 0.0002%
24/7/26 Tax

Compliance Officer

-1,201 0.0002%
23/2/26 Tax

Compliance Officer

2,376 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%-1.68% - - 9.13B
-0.79%+1.61%-16.23%+5.18% 191B
-0.73%+1.33%-2.60%+11.08% 116B
-0.41%-3.84%+6.73%+73.62% 59.64B
-0.42%+1.08%+34.00%+70.00% 55.42B
-0.71%+1.37%-7.07%-33.92% 49.6B
-1.10%+1.27%+9.65%-17.67% 33.49B
-2.41%+3.16% - - 30.6B
-1.60%-0.79%-7.55%+24.99% 24.25B
-0.80%-1.57%+40.78%-11.77% 24.39B
Average -1.01%+0.40%+7.21%+15.19% 59.35B
Weighted average by Cap. -0.84%+0.77%-0.60%+15.51%

Financials

2026 *2027 *
Net sales 6.59B 5.69B 5.34B 4.86B 9.15B 630B 9.27B 62.6B 24.53B 316B 24.76B 24.22B 1,051B 6.75B 5.83B 5.47B 4.98B 9.36B 645B 9.49B 64.08B 25.11B 323B 25.34B 24.79B 1,076B
Net income 225M 194M 182M 166M 312M 21.53B 317M 2.14B 838M 10.78B 845M 827M 35.87B 311M 268M 252M 229M 431M 29.71B 437M 2.95B 1.16B 14.89B 1.17B 1.14B 49.52B
Net Debt 3.07B 2.65B 2.49B 2.27B 4.26B 294B 4.32B 29.17B 11.43B 147B 11.54B 11.29B 490B 2.44B 2.11B 1.98B 1.8B 3.39B 233B 3.43B 23.18B 9.08B 117B 9.17B 8.97B 389B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
17/08/26 USD 13.50 -1.17% 4,537,083
14/08/26 USD 13.66 -1.37% 3,964,759
13/08/26 USD 13.85 -0.57% 5,935,599
12/08/26 USD 13.93 +1.16% 6,196,739
11/08/26 USD 13.77 +0.29% 7,644,967
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
13.50USD
Average target price
14.56USD
Spread / Average Target
+7.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock